Allspring Global Investments Holdings, LLC Xeris Biopharma Holdings, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $59.4 Billion
- Q2 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 16,282 shares of XERS stock, worth $46,729. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,282
Previous 353
4512.46%
Holding current value
$46,729
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding XERS
# of Institutions
133Shares Held
57MCall Options Held
126KPut Options Held
45K-
Black Rock Inc. New York, NY10.3MShares$29.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.66MShares$22 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$14.7 Million61.49% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.83MShares$13.9 Million1.75% of portfolio
-
State Street Corp Boston, MA3.26MShares$9.35 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $390M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...